Sponsor Pipeline

EyeGene Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07204457 Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults… Meningococcal Infections Recruiting
Get alerts when EyeGene Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free